New Drug Holds Promise in Triple Negative Breast Cancer Fight

Lab studies and early trials show the drug BSI-201, or iniparib, is markedly effective in reducing tumors when used alongside other chemotherapy drugs.

Chemotherapy Now Recommended for Pregnant Women with Breast Cancer

New data from researchers at MD Anderson Cancer Center has revealed that pregnant women treated with chemotherapy for breast cancer do at least as well as non-pregnant women.

Breast Density Linked to Breast Cancer Recurrence

Recent study indicates that women with dense breast tissue have a higher risk of recurrence.